The present invention relates to ablation devices.
In treatment of arrhythmia in the related art, ablation devices that linearly cauterize the cardiac surfaces are used (for example, see Patent Literature 1 and Non Patent Literature 1). In atrial cells, an abnormal electric signal is generated mainly near the pulmonary vein of the left atrium. Therefore, by linearly cauterizing the left atrium so as to surround the base of the pulmonary vein, the abnormal electric signal can be prevented from being transmitted from the pulmonary vein to the surrounding area thereof.
A known minimally-invasive heart surgery method involves percutaneously inserting a treatment device into the pericardial cavity through the pericardium from the xiphoid process.
Electrodes for supplying high-frequency current to the heart are provided not around the entire circumference of the ablation device but only in one area in the circumferential direction. Therefore, in order to reliably cauterize the cardiac surface, the orientation of the ablation device around the longitudinal axis has to be adjusted so that the electrodes come into contact with the cardiac surface.
An object of the present invention is to provide an ablation device that allows the orientation of a cauterizing surface percutaneously inserted in the body to be externally recognized so that tissue can be reliably cauterized.
A first aspect of the present invention provides an ablation device including a narrow insertion section insertable into a body, a distal end section provided at a distal end of the insertion section and having a narrow cauterizing surface that is formed in a longitudinal direction in one area in a circumferential direction and that releases energy to biological tissue, and a radiopaque marking section provided at the distal end section and substantially parallel to the cauterizing surface. The marking section has a three-dimensional shape such that projection shapes obtained when projected from different sides in a radial direction of the distal end section are different from each other.
In the above aspect, the marking section may be provided at the cauterizing surface or may be provided at a side surface of the distal end section that is substantially orthogonal to the cauterizing surface.
In the above aspect, the marking section may include a plurality of markers arranged in the longitudinal direction in a row at an intervals.
In the above aspect, the ablation device may further include an insulation member having electrical insulation properties and accommodating the distal end section and the insertion section in a movable manner in the longitudinal direction.
An ablation device 1 according to an embodiment of the present invention will be described below with reference to the drawings.
As shown in
The insertion section 2 and the distal end section 3 have flexibility such that they are bendable in conformity to the shape of surrounding tissue, and are percutaneously insertable into the pericardial cavity.
The cauterizing surface 6 has a narrow rectangular shape extending in the longitudinal direction.
The cauterizing section 7 is constituted of a plurality of electrodes 10 spaced apart from one another and arranged in a row in the longitudinal direction. In the drawings, only one of the plurality of electrodes is given the reference sign 10. The electrodes 10, which are composed of a conductive material, such as metal, have X-ray impermeability. The electrodes 10 are exposed to the outside so as to be directly contactable with tissue. Moreover, the electrodes 10 are electrically connected to the power supply unit 5 by wires that extend inside the distal end section 3, the insertion section 2, and the handle 4 to the power supply unit 5.
The marking section 8 is constituted of a single flat and narrow strip-shaped marker 11 composed of a radiopaque material, such as platinum or palladium. The marker 11 is provided parallel to the cauterizing surface 6. Furthermore, the marker 11 is spaced apart from the cauterizing section 7 and is provided parallel to the cauterizing section 7 along the entire length of the cauterizing section 7.
Next, the operation of the ablation device 1 having the above-described configuration will be described.
The ablation device 1 according to this embodiment is used in treatment that involves directly ablating the cardiac surface from the outside.
First, for example, a guide wire is inserted into the body from below the xiphoid process and is pierced through the pericardium so as to be inserted into the pericardial cavity. Then, the guide wire is inserted into the guide wire hole 9, and the distal end section 3 and the insertion section 2 are moved forward along the guide wire, thereby introducing the distal end section 3 and the insertion section 2 into the pericardial cavity. The guide wire, the distal end section 3, and the insertion section 2 are operated inside the body while observing the patient's thorax by using an X-ray fluoroscope.
Then, for example, as shown in
The relationship between the orientation (i.e., the rotational angle around the longitudinal axis) of the distal end section 3 inside the pericardial cavity and the shapes of projection images of the cauterizing section 7 and the marking section 8 in an X-ray fluoroscopic image will now be described.
In a case where the abdomen of a patient lying facing upward is to be observed from top to bottom in the vertical direction by using an X-ray fluoroscope, when the cauterizing surface 6 is facing vertically upward, the shapes of the projection images of the cauterizing section 7 and the marking section 8 in the X-ray fluoroscopic image are identical to the shapes of the cauterizing section 7 and the marking section 8 shown in
When the cauterizing surface 6 is facing vertically downward, the shapes of the projection images of the cauterizing section 7 and the marking section 8 in the X-ray fluoroscopic image are such that the cauterizing section 7 and the marking section 8 in
When the cauterizing surface 6 is tilted relative to the vertical direction, the shapes of the projection images of the cauterizing section 7 and the marking section 8 in the X-ray fluoroscopic image are such that the cauterizing section 7 and the marking section 8 in
Accordingly, in this embodiment, the cauterizing section 7 and the marking section 8 collectively have a three-dimensional shape such that, when they are projected in the radial direction of the distal end section 3 from the cauterizing surface 6 side, the projection shapes thereof are asymmetrical in the width direction, which intersects the longitudinal axis of the distal end section 3. Therefore, the shapes of the projection images of the combination of the cauterizing section 7 and the marking section 8 in the X-ray fluoroscopic image vary depending on from which side, in the radial direction of the distal end section 3, observation is performed using the X-ray fluoroscope.
Accordingly, a surgeon can recognize the orientation of the distal end section 3 inside the pericardial cavity from the shapes of the projection images of the combination of the cauterizing section 7 and the marking section 8 in the X-ray fluoroscopic image. This is advantageous in that the surgeon can effectively treat a disease, such as arrhythmia, by properly adjusting the orientation of the distal end section 3 so that the cauterizing surface 6 comes into contact with the cardiac surface, and by reliably supplying high-frequency current from the electrodes 10 to the cardiac tissue.
The distal end section 3 is provided with the strip-shaped marking section 8 extending continuously in the longitudinal direction. This marking section 8 deforms spirally as the distal end section 3 is twisted around the longitudinal axis. This advantageous in that the surgeon can recognize whether or not the distal end section 3 is twisted and can recognize the degree of twisting from the overall shape of the marking section 8 in the X-ray fluoroscopic image. Moreover, the cauterizing surface 6 provided with the cauterizing section 7 is also provided with the marking section 8. This is advantageous in that the orientation of the cauterizing surface 6 relative to the cardiac tissue can be recognized more accurately.
In this embodiment, the marking section 8 is constituted of the single marker 11. Alternatively, as shown in
In this embodiment, the cauterizing section 7 and the marking section 8 are both composed of a radiopaque material, and the orientation of the distal end section 3 is identified based on the projection images of the combination of the cauterizing section 7 and the marking section 8. Alternatively, as shown in
In a modification shown in
In the case of the marking section 8 in
In a modification shown in
Although the marking section 8 is provided on the same cauterizing surface 6 as the cauterizing section 7 in this embodiment, the disposition of the marking section 8 is not limited to this.
In a modification shown in
In a modification shown in
In this embodiment, a tubular insulation member 12 that accommodates the insertion section 2 may be further provided, as shown in
The insulation member 12 has an inner diameter slightly larger than the outer diameters of the insertion section 2 and the distal end section 3 and accommodates the insertion section 2 and the distal end section 3 in a movable manner in the longitudinal direction. The insulation member 12 has electrical insulation properties and blocks high-frequency current supplied to the electrodes 10 positioned inside the insulation member 12. A marker 13 composed of a radiopaque material is provided near the distal end of the insulation member 12, so that the position of the distal end of the insulation member 12 inside the body can be recognized in the X-ray fluoroscopic image.
The insulation member 12 is disposed relative to the insertion section 2 and the distal end section 3 at a position where one or more electrodes located toward the base end among the plurality of electrodes 10 are hidden relative to surrounding tissue so that the length of a region to be cauterized can be changed. Moreover, a desired region to be treated can be selectively cauterized while using the insulation member 12 to protect tissue adjoining the region to be treated from the high-frequency current.
Although the cauterizing section 7 is provided with the electrodes 10 for high-frequency ablation in this embodiment, the cauterizing section 7 may alternatively be provided with a heating element for thermal ablation or a cooling element for cryoablation. If a heating element or a cooling element is used, the heating element or the cooling element may be provided inside the distal end section 3, as shown in
As a result, the following aspect is read by the above described embodiment of the present invention.
A first aspect of the present invention provides an ablation device including a narrow insertion section insertable into a body, a distal end section provided at a distal end of the insertion section and having a narrow cauterizing surface that is formed in a longitudinal direction in one area in a circumferential direction and that releases energy to biological tissue, and a radiopaque marking section provided at the distal end section and substantially parallel to the cauterizing surface. The marking section has a three-dimensional shape such that projection shapes obtained when projected from different sides in a radial direction of the distal end section are different from each other.
According to the aspect of the present invention, tissue can be linearly cauterized along the narrow cauterizing surface by percutaneously inserting the insertion section into the body and releasing energy from the cauterizing surface.
In this case, a surgeon operates the insertion section while using an X-ray fluoroscope to observe the radiopaque marking section provided at the distal end section and substantially parallel to the cauterizing surface. The shape of a projection image of the marking section in an X-ray fluoroscopic image varies depending on the orientation of the distal end section (i.e., the rotational angle around the longitudinal axis of the distal end section) relative to the direction of observation using the X-ray fluoroscope. Therefore, the surgeon can externally recognize the orientation of the cauterizing surface inside the body based on the shape of the projection image of the marking section in the X-ray fluoroscopic image and properly adjust the orientation of the distal end section so as to bring the cauterizing surface into contact with the tissue, whereby the tissue can be reliably cauterized.
In the above aspect, the marking section may be provided at the cauterizing surface or may be provided at a side surface of the distal end section that is substantially orthogonal to the cauterizing surface.
Accordingly, the marking section can be suitably disposed in accordance with the intended use.
In the above aspect, the marking section may include a plurality of markers arranged in the longitudinal direction in a row at an intervals.
Accordingly, the markers can be used as a scale indicating positions in the longitudinal direction of the distal end section so that it can be quantitatively recognized whether the cauterizing surface is in contact with the tissue at any of the positions of the distal end section in the longitudinal direction or whether the cauterizing surface is not in contact with the tissue.
In the above aspect, the ablation device may further include an insulation member having electrical insulation properties and accommodating the distal end section and the insertion section in a movable manner in the longitudinal direction.
Accordingly, by accommodating a base-end section of the cauterizing surface within the insulation member, the length of a region to be cauterized can be changed. Moreover, a desired region can be selectively cauterized while protecting an adjoining region from the high-frequency current.
This is a continuation of International Application PCT/JP2014/081499, with an international filing date of Nov. 28, 2014, which is hereby incorporated by reference herein in its entirety. This application claims the benefit of International Application PCT/JP2014/081499.
Number | Date | Country | |
---|---|---|---|
Parent | PCT/JP2014/081499 | Nov 2014 | US |
Child | 15598917 | US |